Page 31 - THE ROMANIAN HEALTH CARE

in

cluster Romania is bioROne (see the textbox). Cooperation in a cluster is today a

mainstream organisation model, for bio-medical R&D.

The three main bio-medical clusters are in Romania:

1. bioROne – biotechnology: www.biotechnologie.ro

2. RoHealth – health and bioeconomy: www.rohealth.ro

3. iMAGO-MOL – molecular imaging: www.imago-mol.ro

of

Commercialisation knowledge (part of translational research) is very difficult, as there is no

legal framework for translational research. Anti-corruption legislation and fear to be sued for

paralysing sensible development in this field. Universities are afraid to receive
corruption is

money from companies, hence this inhibits any form of contract research. Governmental

institutions are not helping when asked about the application of relevant laws, either no

is

answer given or a copy-paste from the law/regulation is given as answer. People are afraid

to act. To further develop the clusters there is the need for a success story, that can act as

role model.

4.4 Opportunities for cooperation

Cooperation between Romanian and Dutch governmental organisations, universities and

institutes is possible in several fields.

1. In Romania health economics is a highly underdeveloped field. Romanian healthcare

can be improved substantially by making research based economic decisions. This can

be done in many areas, for example decisions on the locations of new hospitals.

Admittance of new medicines or medical devices to the Romanian market, and

establishing if the costs are acceptable, instead of decisions based on private interests.

The Netherlands has a number institutes that are specialised in this fields.

2. In the field of public health cooperation should be feasible. In the Netherlands

extensive knowledge is available on public health and epidemiology.

3. Health technology assessment is underdeveloped in Romania and could use input

from the Netherlands.

4. Romanian organisations in the field of scientific research and R&D are isolated from

EU counterparts. Connecting Romanian scientific research and R&D to EU partners,

can open new opportunities.

29